1Molecular Signaling and Drug Discovery Laboratory, Department of Biochemistry, School of Basic and Applied Sciences, Central University of Punjab, Bathinda 151401, India.
2Department of Urology, Case Western Reserve University, Cleveland, OH 44106, USA.
3Department of Urology, The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
4Department of Nutrition, Case Western Reserve University, Cleveland, OH 44106, USA.
5Divison of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA.
6Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Epidemiological studies suggest a close association between diet and cancer initiation, which provides evidence that the dietary components may be effectively developed as chemopreventive agents. These pieces of evidence are further supported by several case-control and cohort studies, which overwhelmingly support a converse association between the intake of phytochemicals and cancer risk[2,3]. A number of clinical studies have been conducted demonstrating that dietary phytochemicals have the ability to inhibit tumorigenesis. Components presenting in fruit and vegetables termed “bioactive” phytochemicals belong to several classes of micronutrients, including flavonoids, polyphenols, and dietary fiber. These components have the ability to reduce the cancer risk alone or by interactions between them.
Cancer chemoprevention is a means to control, slow, or reverse of cancer occurrence by administrating one or more synthetic or naturally occurring compounds. Chemoprevention also implies the prevention of precancerous lesions, such as pre-invasive neoplasia, dysplasia, or intraepithelial neoplasia, depending on the organ system. Therefore, phytochemicals serve as chemopreventive agents that could be beneficial for the prevention of all aspects of carcinogenesis.
The special issue on “Phytochemicals and Cancer Chemoprevention” contains original research and review articles is aimed to stimulate the continuous efforts to understand the identification, development and use of phytochemicals for cancer prevention and treatment. It has been estimated that more than two-thirds of human cancers are preventable through proper diet and lifestyle changes. In 1981, Doll and Peto reported that 30%-40% of human cancer is preventable, and its mortality is attributed to diet. Their observations were based on statistical and epidemiological data with major concerns on dietary factors that increase cancer risk. Although the exact percentage is uncertain, compelling evidence from epidemiological, clinical, and laboratory studies suggest a link between cancer risk and nutritional factors.
Several phytochemicals have been identified as bioactive agents which possess cancer preventive and therapeutic properties. Dave et al. reviewed some well-established natural phytochemicals as cancer chemopreventive agents, including resveratrol (grapes), epigallocatechin-3-gallate (green tea), sulforaphane (cruciferous vegetables), anthocyanins (grapes and berries), curcumin (turmeric), silibinin (milk thistle), and lycopene (tomatoes). As appropriately demonstrated by the genomic analysis and other methods, the mechanistic underpinning remains variable and complex. The authors further suggest that these responses may be mediated through indirect mechanisms, including interaction with the microbiome. In addition, ancillary applications of the chemopreventive-agents remains worth considering, such as the management of chemotherapy induced sequelae. Recognizing the loss of millions of cancer patients every year, it is obvious that negating malignant metastatic conditions remains of paramount importance. In meeting these goals, cancer chemoprevention by phytochemicals offers great promise.
The importance of phytochemicals lies in their superior properties of reducing side-effects, efficacy in chronic conditions, cost-effectiveness, and widespread usage of natural compounds. The manuscript by Kushwaha et al. has proposed using phytochemicals in cancer chemotherapy having a promising future. Through in silico approach, the authors have shown that the phytochemicals present in Bulbine frutescens
Another review article published by Yeger and Mokhtari discussed the isothiocyanates family of naturally occurring small molecules generated from the glucosinolate precursors of cruciferous vegetables. The cancer chemopreventive roles of some key isothiocyanates such as sulforaphane, phenethylisothiocyanate, and benzyl isothiocyanate have been studied in preclinical and clinical settings. In the review article, the authors have presented a broader perspective on the isothiocynates, including their research on sulforaphane-mediated cancer prevention and treatment. The authors further discussed the hormetic effects which might affect the efficacy of these agents, and their role as anti-inflammatory molecules with insights into potential therapeutic applications.
The review article by Grynkiewicz discussed the research on isoflavones in human health. Flavonoids are a large family of polyphenols that include over 6000 members widely distributed in the plant kingdom. Isoflavones, a subfamily of flavonoids, is the main focus of the review. These compounds are major constituents present in soybeans, soy foods, and legumes possessing antioxidant, antimicrobial, and anti-inflammatory properties. Natural isoflavones belong to the phenylpropanoid category and share considerable chemical and biochemical characteristics as they belong to similar biogenetic pathways. In the review, the author discussed the pharmacology and estrogenic nature of isoflavones. An attempt was also made to mention the hurdles faced in clinical research on isoflavones due to their low solubility and bioavailability. The authors further highlighted new advances in isoflavone research by chemical derivatization and developed a suitable bioavailability-enhancing formulation for further research.
The special issue concludes with the article by Wenner et al., discussing the molecular mechanisms of chemoprevention elicited by the phytochemicals against various diseases, including cancer. The authors discussed the cellular process of autophagy and an evolutionarily conserved self-digestion process that employs lysosomal-mediated enzymatic degradation. The authors discussed the autophagy induction potential of phytochemicals such as phenethyl isothiocyanate, capsaicin, withaferin A and genistein. Molecular pathway context dependent cytoprotective/cytotoxic role of autophagy and its role in cancer chemoprevention were also discussed. Understanding the pharmacology of these phytochemicals used alone or in combination with other conventional therapies, could lead to the development of new approaches in health promotion and disease prevention.
Made substantial contributions to conception and writing of the manuscript: Gupta S
Participated in review, type setting, referencing of the manuscript: Kumar S
Provided administrative, technical, and material support: Gupta SAvailability of data and materials
Not applicable.Financial support and sponsorship
Efforts are supported by the Department of Defense Grants W81XWH-18-1-0618 and W81XWH-19-1-0720 and VA Merit Review 1I01BX002494 to Gupta S. Kumar S acknowledges University Grants Commission, India and Department of Science and Technology, India for providing financial support in the form of UGC-BSR Research Start-Up-Grant [No. F.30-372/2017 (BSR)] and DST-SERB Grant [EEQ/2016/000350]. Kumar S acknowledges Central University of Punjab, Bathinda, India for providing Research Seed Money Grant [GP-25].Conflicts of interest
Both authors declare that there are no conflicts of interest.Ethical approval and consent to participate
Not applicable.Consent for publication
© The Author(s) 2021.
1. Ruiz R, Salinas Hernández P. Cancer chemoprevention by dietary phytochemicals: epidemiological evidence. Maturitas 2016;94:13-9.DOIPubMed
2. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev 2005;14:139-42.DOIPubMed
3. Fujiki H, Sueoka E, Watanabe T, Suganuma M. Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J Cancer Prev 2015;20:1-4.DOIPubMed PMC
4. Kotecha R, Takami A, Espinoza JL. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 2016;7:52517-29.DOIPubMed PMC
5. Pan MH, Ho CT. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008;37:2558-74.DOIPubMed
6. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.PubMed
7. Dave A, Parande F, Park EJ, Pezzuto JM. Phytochemicals and cancer chemoprevention. J Cancer Metastasis Treat 2020;6:46.DOI
8. Kushwaha PP, Maurya SK, Singh A, et al. Bulbine frutescens phytochemicals as novel ABC-transporter inhibitor: a molecular docking and molecular dynamics simulation study. J Cancer Metastasis Treat 2021;7:2.DOI
9. Yeger H, Mokhtari RB. Perspective on dietary isothiocyanates in the prevention, development and treatment of cancer. J Cancer Metastasis Treat 2020;6:26.DOI
10. Grynkiewicz G. Isoflavone research towards healthcare applications. J Cancer Metastasis Treat 2020;6:48.DOI
11. Wenner C, Stewart R, McCabe A, et al. Role of autophagic response induced by major phytochemicals in cancer prevention and treatment. J Cancer Metastasis Treat 2020;6:33.DOI
Kumar S, Gupta S. Dietary phytochemicals and their role in cancer chemoprevention. J Cancer Metastasis Treat 2021;7:51. http://dx.doi.org/10.20517/2394-4722.2021.125